The role of doxycycline in the management of chronic rhinosinusitis with nasal polyps

Keyphrases

• Doxycycline 100%
• Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) 100%
• Placebo Groups 40%
• Visual Analog Scale 40%
• High Dropout Rate 40%
• Nasal Polyp Score 40%
• Patient Management 20%
• No Significant Difference 20%
• Severe Disease 20%
• Placebo 20%
• Randomized Placebo-controlled Trial 20%
• Limited Samples 20%
• Patient Demographics 20%
• Oral Corticosteroids 20%
• Treatment Group 20%
• Patient Outcomes 20%
• Dropout 20%
• Medical Therapy 20%
• Moderate Disease 20%
• Asthma Exacerbation 20%
• SNOT-22 Score 20%
• SNOT-22 20%
• Tertiary Level 20%
• Effective Management 20%
• Sino-Nasal Outcome Test 20%
• Non-surgical Management 20%
• Antibacterial Properties 20%
• Reasons for Dropout 20%
• Durable Effect 20%

Medicine and Dentistry

• Doxycycline 100%
• Chronic Rhinosinusitis 100%
• Nasal Polyp 100%
• Placebo 57%
• Anti-Inflammatory Drug 28%
• Visual Analog Scale 28%
• Diseases 28%
• Patient Population 14%
• Pathophysiology 14%
• Arm 14%
• Asthma Exacerbation 14%
• Antibacterial Activity 14%
• Surgery 14%
• Treatment Group 14%
• Corticosteroid 14%
• Oral 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Doxycycline 100%
• Nose Polyp 100%
• Chronic Rhinosinusitis 100%
• Placebo 57%
• Anti-Inflammatory Drug 28%
• Diseases 28%
• Antiinfective Agent 14%
• Pathophysiology 14%
• Asthma 14%
• Treatment Group 14%
• Corticosteroid 14%